Drew James Adams

2009 Harvard University, Cambridge, MA, United States 
"Drew Adams"
Mean distance: 7.65


Sign in to add mentor
David A. Evans grad student 2009 Harvard
 (Total synthesis of Galbulimima alkaloids: (1) GB 13 and himgaline; (2) Studies toward himandridine.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Caprariello AV, Adams DJ. (2022) The landscape of targets and lead molecules for remyelination. Nature Chemical Biology. 18: 925-933
Sax JL, Hershman SN, Hubler Z, et al. (2022) Enhancers of Human and Rodent Oligodendrocyte Formation Predominantly Induce Cholesterol Precursor Accumulation. Acs Chemical Biology
Pleshinger MJ, Friedrich RM, Hubler Z, et al. (2021) Inhibition of SC4MOL and HSD17B7 shifts cellular sterol composition and promotes oligodendrocyte formation. Rsc Chemical Biology. 3: 56-68
Sax JL, Hubler Z, Allimuthu D, et al. (2021) Screening Reveals Sterol Derivatives with Pro-Differentiation, Pro-Survival, or Potent Cytotoxic Effects on Oligodendrocyte Progenitor Cells. Acs Chemical Biology
Hubler Z, Friedrich RM, Sax JL, et al. (2021) Modulation of lanosterol synthase drives 24,25-epoxysterol synthesis and oligodendrocyte formation. Cell Chemical Biology
Factor DC, Barbeau AM, Allan KC, et al. (2020) Cell Type-Specific Intralocus Interactions Reveal Oligodendrocyte Mechanisms in MS. Cell
Ogino M, Fedorov Y, Adams DJ, et al. (2019) Vesiculopolins, a New Class of Anti-Vesiculoviral Compounds, Inhibit Transcription Initiation of Vesiculoviruses. Viruses. 11
Bayles I, Krajewska M, Pontius WD, et al. (2019) Ex vivo screen identifies CDK12 as a metastatic vulnerability in osteosarcoma. The Journal of Clinical Investigation
Allimuthu D, Hubler Z, Najm FJ, et al. (2019) Diverse Chemical Scaffolds Enhance Oligodendrocyte Formation by Inhibiting CYP51, TM7SF2, or EBP. Cell Chemical Biology
Belur Nagaraj A, Joseph P, Ponting E, et al. (2019) A miRNA-Mediated Approach to Dissect the Complexity of Tumor-Initiating Cell Function and Identify miRNA-Targeting Drugs. Stem Cell Reports. 12: 122-134
See more...